Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2601-2612
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2601
Table 2 Relationship of ROR2 and WNT5a expression with the clinicopathologic characteristics of gallbladder squamous/adenosquamous carcinoma n (%)
Pathologic characteristicNumber of casesROR2
WNT5a
Positive casesχ2P valuePositive casesχ2P value
Pathological type
Squamous carcinoma2616 (61.5)0.6120.43417 (65.4)0.1410.708
Adenosquamous carcinoma2010 (50.0)12 (60.0)
Differentiation
High165 (31.3)9.1230.0108 (50.0)1.8270.401
Moderate2415 (62.5)17 (70.8)
Poor66 (100.0)4 (66.7)
Maximal diameter of the mass in cm
≤ 3207 (35.0)6.6690.0109 (45.0)4.9450.026
≥ 32619 (73.1)20 (76.9)
Gallstones
No1811 (61.1)0.2530.61512 (66.7)0.1670.683
Yes2815 (53.6)17 (60.7)
TNM stage
I + II124 (33.3)4 (33.3)
III2010 (50.0)7.8240.02314 (70.0)6.4110.041
IV1412 (85.7)11 (78.6)
Lymph node metastasis
No175 (29.4)8.0650.0057 (41.2)6.7200.010
Yes2921 (72.4)22 (75.9)
Invasion of the surrounding tissue
No165 (31.3)6.3760.0117 (43.8)3.9200.048
Yes3021 (70.0)22 (73.3)
Surgical procedure
Radical144 (28.6)7.3740.0225 (35.7)77.6770.019
Palliative1811 (61.1)12 (66.7)
Unresected1411 (78.6)12 (85.7)